New paradigms and tools in drug design for pain and addiction

Journal Title: The AAPS Journal - Year 2006, Vol 8, Issue 3

Abstract

New modalities providing safe and effective treatment of pain, especially prolonged pathological pain, have not appeared despite much effort. In this mini-review/overview we suggest that new paradigms of drug design are required to counter the underlying changes that occur in the nervous system that may elicit chronic pain states. We illustrate this approach with the example of designing, in a single ligand, molecules that have agonist activity at μ and σ opioid receptors and antagonist activities at cholecystokinin (CCK) receptors. Our findings thus far provide evidence in support of this new approach to drug design. We also report on a new biophysical method, plasmon waveguide resonance (PWR) spectroscopy, which can provide new insights into information transduction in g-protein coupled receptors (GPCRs) as illustrated by the δ opioid receptor.

Authors and Affiliations

Victor J. Hruby, Frank Porreca, Henry I. Yamamura, Gordon Tollin, Richard S. Agnes, Yeon Sun Lee, Minying Cai, Isabel Alves, Scott Cowell, Eva Varga, Peg Davis, Zdzislaw Salamon, William Roeske, Todd Vanderah, Josephine Lai

Keywords

Related Articles

Integrated Pharmacokinetic-Driven Approach to Screen Candidate Anticancer Drugs for Brain Tumor Chemotherapy

The online version of this article (doi:10.1208/s12248-012-9428-4) contains supplementary material, which is available to authorized users.

Antidrug Antibody Assay Validation: Industry Survey Results

Immunogenicity of biopharmaceutical products has attracted considerable attention from the industrial, academia, and regulatory organizations. Many methods exist to detect and characterize level of antidrug antibody resp...

Particle size analysis of concentrated phospholipid microemulsions: I. Total intensity light scattering

Water-in-oil phospholipid microemulsions prepared from a constant total surfactant/cosurfactant concentration of 25 wt% at four different lecithin/alcohol weight ratios (Km of 1∶1, 1.5∶1, 1.77∶1,...

Structure–Activity Relationships of Tariquidar Analogs as Multidrug Resistance Modulators

The review summarizes the most recent achievements in structure–activity relationship (SAR) studies of tariquidar and its analogs. Tariquidar is one of the most promising representatives of the third generation o...

Influence of Surface Chemistry on Cytotoxicity and Cellular Uptake of Nanocapsules in Breast Cancer and Phagocytic Cells

The online version of this article (doi:10.1208/s12248-014-9572-0) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681800
  • DOI  10.1208/aapsj080353
  • Views 110
  • Downloads 0

How To Cite

Victor J. Hruby, Frank Porreca, Henry I. Yamamura, Gordon Tollin, Richard S. Agnes, Yeon Sun Lee, Minying Cai, Isabel Alves, Scott Cowell, Eva Varga, Peg Davis, Zdzislaw Salamon, William Roeske, Todd Vanderah, Josephine Lai (2006). New paradigms and tools in drug design for pain and addiction. The AAPS Journal, 8(3), -. https://europub.co.uk/articles/-A-681800